Citation Impact

4 from Science/Nature 54 standout
Sub-graph 1 of 23

Citing Papers

Expanded ROS Generation and Hypoxia Reversal: Excipient‐free Self‐assembled Nanotheranostics for Enhanced Cancer Photodynamic Immunotherapy
2024 Standout
Transcription–replication conflicts underlie sensitivity to PARP inhibitors
2024 StandoutNature
6 intermediate papers

Works of Baskar Mannargudi being referenced

A Phase I Combination Study of Olaparib with Cisplatin and Gemcitabine in Adults with Solid Tumors
2012
A Phase I Study of PF-04929113 (SNX-5422), an Orally Bioavailable Heat Shock Protein 90 Inhibitor, in Patients with Refractory Solid Tumor Malignancies and Lymphomas
2011

Author Peers

Author Oncology Immunology Molecular Biology Last Decade Papers Cites
Baskar Mannargudi 203 85 232 11 470
S N Nadel 43 7 20 433
Hsiang Ho 64 169 331 13 658
L. Buckle 45 786
T. Korsen 3 19 45 17 701
A Chicoye 5 3 3 17 498

All Works

Loading papers...

Rankless by CCL
2026